Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06013995
PHASE1

A Study to Investigate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986326 in Adult Participants With Different Forms of Lupus

Sponsor: Bristol-Myers Squibb

View on ClinicalTrials.gov

Summary

The purpose of this study is to evaluate safety, drug levels and drug effects on cells and organs of the body, after receiving multiple increasing doses of BMS-986326 via intravenous (IV) infusion or subcutaneous (SC) injection, in participants with different forms of lupus.

Official title: A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986326 in Adult Participants With Discoid Lupus Erythematosus, Subacute Cutaneous Lupus Erythematosus, or Systemic Lupus Erythematosus

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

44

Start Date

2023-09-21

Completion Date

2026-04-08

Last Updated

2026-04-01

Healthy Volunteers

No

Conditions

Interventions

DRUG

BMS-986326

Specified dose on specified days

OTHER

Placebo for BMS-986326

Specified dose on specified days

Locations (27)

Local Institution - 0048

San Diego, California, United States

Local Institution - 0055

Clearwater, Florida, United States

Local Institution - 0029

Tampa, Florida, United States

North Georgia Rheumatology

Lawrenceville, Georgia, United States

Skin Sciences

Louisville, Kentucky, United States

Local Institution - 0062

Las Vegas, Nevada, United States

Columbia University Irving Medical Center

New York, New York, United States

Local Institution - 0005

Duncansville, Pennsylvania, United States

Allen Arthritis

Allen, Texas, United States

Metroplex Clinical Research Center

Dallas, Texas, United States

Arthritis Northwest, PLLC

Spokane, Washington, United States

Hospital Universitario Austral

Pilar, Buenos Aires, Argentina

Clinica Adventista Belgrano

CABA, Buenos Aires F.D., Argentina

Local Institution - 0072

Sofia, Bulgaria

Local Institution - 0044

Berlin, Germany

Local Institution - 0071

Dessau, Germany

Local Institution - 0047

Dresden, Germany

Local Institution - 0073

Cuauhtémoc, Ciudad de México, DIF, Mexico

Local Institution - 0068

Mexico City, DIF, Mexico

Local Institution - 0077

Chihuahua City, Mexico

Local Institution - 0051

Leiden, Netherlands

Local Institution - 0074

Poznan, Poland

Local Institution - 0069

Warsaw, Poland

Local Institution - 0065

Bucharest, București, Romania

Local Institution - 0064

Cluj-Napoca, Cluj, Romania

Local Institution - 0046

A Coruña, A Coruña [La Coruña], Spain

Local Institution - 0045

Córdoba, Córdoba, Spain